billSRES780Event Thursday, June 18, 2026Analyzed

A resolution expressing support for the designation of June 19, 2026, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

Neutral

Summary

SRES780 is a non-binding resolution expressing support for World Sickle Cell Awareness Day. It does not authorize or appropriate any funding, impose any mandates, or create any regulatory changes. The bill is in early legislative stage, referred to the Committee on Foreign Relations, with no market impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.SRES780 is a non-binding, symbolic resolution with no legislative force.
  • 2.No funding, mandates, or regulatory changes are created by this bill.
  • 3.The bill has zero near-term market impact for any sector or company.

Market Implications

No market implications. This is a procedural, non-binding resolution that does not affect any company's revenue, costs, or competitive position. Retail investors should ignore this bill for any investment decision.

Full Analysis

This resolution (SRES780) was introduced on June 18, 2026, by Senator Booker (D-NJ) and referred to the Senate Committee on Foreign Relations. It is a symbolic measure expressing support for designating June 19, 2026, as 'World Sickle Cell Awareness Day.' The bill does not create any new programs, authorize spending, or impose regulatory requirements. It is purely aspirational and has no binding effect on any government agency or private entity. As a non-binding resolution in early stage with only one cosponsor, it carries no legislative momentum that would affect any sector or company. No funding is authorized or appropriated. The bill's path forward is uncertain; it may be passed by unanimous consent or simply expire without action. There is no market implication for any publicly traded company.

Key Legislators

Sen. Booker, Cory A. [D-NJ]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →